Literature DB >> 21865130

HER2 in gastric cancer: a biomarker with clinical impact, but not without translational challenges.

Florian Lordick.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21865130     DOI： 10.1007/s12094-011-0704-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  4 in total

1.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Authors:  Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Journal:  Lancet       Date:  2010-08-19       Impact factor: 79.321

2.  Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

Authors:  Carlos Gómez-Martín; Angel Concha; José María Corominas; Tomás García-Caballero; Elena García-García; Mar Iglesias; José Antonio López; Santiago Ramón y Cajal; Federico Rojo; José Palacios; Francisco Vera-Sempere; Enrique Aranda; Ramon Colomer; Pilar García-Alfonso; Pilar Garrido; Fernando Rivera; Fernando López-Ríos
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

3.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

4.  HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.

Authors:  Josef Rüschoff; Manfred Dietel; Gustavo Baretton; Susanne Arbogast; Axel Walch; Geneviéve Monges; Marie-Pierre Chenard; Frédérique Penault-Llorca; Iris Nagelmeier; Werner Schlake; H Höfler; H H Kreipe
Journal:  Virchows Arch       Date:  2010-07-28       Impact factor: 4.064
  4 in total
  4 in total

Review 1.  Clinical impact of tumour biology in the management of gastroesophageal cancer.

Authors:  Florian Lordick; Yelena Y Janjigian
Journal:  Nat Rev Clin Oncol       Date:  2016-03-01       Impact factor: 66.675

2.  [Treatment of gastric cancer].

Authors:  F Lordick; A Hoffmeister
Journal:  Internist (Berl)       Date:  2014-01       Impact factor: 0.743

Review 3.  Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Authors:  Florian Lordick; Sylvie Lorenzen; Yasuhide Yamada; David Ilson
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

4.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.